Verona Pharma Files Definitive Proxy Statement for 2025 Annual Meeting
| Field | Detail |
|---|---|
| Company | Verona Pharma PLC |
| Form Type | DEF 14A |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Verona Pharma's proxy statement is out for the April 24th meeting - shareholders vote on directors & more.
AI Summary
Verona Pharma plc filed its definitive proxy statement (DEF 14A) on March 18, 2025, for its annual meeting on April 24, 2025. The filing concerns the solicitation of proxies for the meeting, which will include the election of directors and other corporate matters. Verona Pharma is a pharmaceutical preparations company incorporated in X0 with its principal executive offices in London.
Why It Matters
This filing provides shareholders with crucial information regarding the upcoming annual meeting, including proposals to be voted on and details about the company's leadership, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing for an annual shareholder meeting, not indicating any immediate operational or financial distress.
Key Numbers
- 114 — Public Documents (Number of documents included in the filing.)
Key Players & Entities
- Verona Pharma plc (company) — Registrant
- 0001104659-25-025050 (filing_id) — Accession Number
- 20250318 (date) — Filing Date
- 20250424 (date) — Conformed Period of Report (Meeting Date)
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the information required in a proxy statement for the solicitation of proxies for Verona Pharma plc's annual meeting of shareholders.
When is the annual meeting of shareholders scheduled to take place?
The annual meeting of shareholders is scheduled to take place on April 24, 2025, as indicated by the 'CONFORMED PERIOD OF REPORT'.
Who is the registrant filing this proxy statement?
The registrant filing this proxy statement is Verona Pharma plc.
What is Verona Pharma plc's industry classification?
Verona Pharma plc is classified under 'PHARMACEUTICAL PREPARATIONS' with the SIC code 2834.
Where are Verona Pharma plc's principal executive offices located?
Verona Pharma plc's principal executive offices are located at 3 MORE LONDON RIVERSIDE, LONDON, SE1 2RE.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 18, 2025 regarding Verona Pharma plc.